MCF7 ZsGreen-ZNF703 Overexpressing Cell Line

Exclusive tool

This is a derivative of the MCF7 breast cancer cell line engineered to overexpress Zinc Finger Protein 703 (ZNF703).

Contributors

Inventor Institute
Carlos Caldas University of Cambridge
SKU: 157969
Product description: This is a derivative of the MCF7 breast cancer cell line engineered to overexpress Zinc Finger Protein 703 (ZNF703).
Conditional: No
Parental cell line: MCF7
Disease: Cancer
Related tools: MCF7 ZsGreen-ZNF703 Lenti-control Cell Line
Cat. #: 157969
Provenance and Ownership: The MCF7 ZsGreen-ZNF703 Overexpressing Cell Line is owned by Cancer Research UK. CancerTools supplies the MCF7 ZsGreen-ZNF703 Overexpressing Cell Line under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing MCF7 ZsGreen-ZNF703 Overexpressing Cell Line directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements.
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Cancer types: Breast cancer
Research Fields: Cancer; Cell signaling and signal transduction
Organism: Human
Tissue: Breast
Model: Knock-In
Format: Frozen
Storage conditions: Liquid Nitrogen
Shipping conditions: Dry ice
Recommended controls: MCF7 parental line
Mycoplasma free: Yes
Biosafety level: 1
References:

Holland et al. 2011. EMBO Mol Med. 3(3):167-80. PMID: 21337521.

Images

View Gallery
ZNF703?amplified tumours are characterized by a lipid metabolism and detoxification gene expression signature and have poor clinical prognosis. Taken from Holland et al. 2011. EMBO Mol Med. 3(3)

Related Tools for Cell lines

Cat. # Tool Name
157971 MCF7 ZsGreen-ZNF703 Lenti-control Cell Line Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.